Skip to main content

This is a preview of improvements coming to the PMC website in October 2024. Learn more

Return to current site
Logo of Cellular and Molecular Life Sciences: CMLS Link to view this article on publisher site
. 2007 Jul 2;64(17):2219–2233. doi: 10.1007/s00018-007-7220-x

Tauopathies

F Hernández 1, J Avila 1,
PMCID: PMC11136052  PMID: 17604998

Abstract.

Tau is a microtubule-associated protein predominantly expressed in nerve cells that promote microtubule assembly and microtubule stabilization. Tau is a cytosolic protein mainly present in axons and involved in anterograde axonal transport. In several neurodegenerative diseases, as for example Alzheimer’s disease, tau metabolism is altered. Thus, alterations in the amount of the tau protein, missense mutations, posttranscriptional modifications like phosphorylation, aberrant tau aggregation or a different expression of some of its isoforms could provoke pathological effects resulting in the appearance of neuronal disorders known as tauopathies. The purpose of this work is to review the possible mechanisms for tau alterations that could lead to the onset of tau pathology. First we will focus on tau turnover, then on tau phosphorylation and, finally, on tau aggregation.

Keywords. Tauopathies, Alzheimer’s disease, FTDP-17, tau, paired helical filaments


Articles from Cellular and Molecular Life Sciences: CMLS are provided here courtesy of Springer

RESOURCES

-